FDA opens Pfizer COVID booster to ages 16 and 17
The U.S. is expanding COVID-19 boosters, ruling that 16- and 17-year-olds can get a third dose of Pfizer’s vaccine.
Full Article
FDA opens Pfizer COVID booster to ages 16 and 17
PIX 11
0 shares
1 views
You might like
Related news coverage
FDA Authorizes Pfizer's COVID-19 Treatment Pill
Newsy
Watch VideoU.S. health regulators on Wednesday authorized the first pill against COVID-19, a Pfizer drug that Americans will be..
Advertisement
More coverage
Colleges go back to drawing board — again — to fight virus
SeattlePI.com
Facing rising infections and a new COVID-19 variant, colleges across the U.S. have once again been thwarted in seeking a move to..